Indications for catheter-directed thrombolysis in the management of acute proximal deep venous thrombosis

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 30, Issue 4, 2010, Pages 669-674

  Patterson, Benjamin O ^a   Hinchliffe, Robert ^a   Loftus, Ian M ^a   Thompson, Matt M ^a   Holt, Peter J E ^a  

^a ST GEORGE'S UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Anticoagulants; Catheter directed thrombolysis; Thrombolysis; Thrombosis

Indexed keywords

ALTEPLASE; ANTICOAGULANT AGENT; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; STREPTOKINASE; UROKINASE; FIBRINOLYTIC AGENT;

ANTICOAGULANT THERAPY; BLOOD CLOT LYSIS; CATHETERIZATION; COMORBIDITY; COST EFFECTIVENESS ANALYSIS; DEEP VEIN THROMBOSIS; HUMAN; LIFE EXPECTANCY; MORBIDITY; MORTALITY; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; THROMBECTOMY; TREATMENT INDICATION; ACUTE DISEASE; COMPRESSION GARMENT; COST BENEFIT ANALYSIS; DRUG COST; ECONOMICS; EVIDENCE BASED MEDICINE; FIBRINOLYTIC THERAPY; HEALTH CARE COST; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; PATIENT SELECTION; POSTTHROMBOSIS SYNDROME; RECURRENT DISEASE; RISK ASSESSMENT; TIME; TREATMENT OUTCOME; VASCULAR PATENCY; VEIN THROMBOSIS; VEIN VALVE;

ACUTE DISEASE; ADMINISTRATION, ORAL; ANTICOAGULANTS; CATHETERIZATION, PERIPHERAL; COST-BENEFIT ANALYSIS; DRUG COSTS; EVIDENCE-BASED MEDICINE; FIBRINOLYTIC AGENTS; HEALTH CARE COSTS; HUMANS; PATIENT SELECTION; POSTTHROMBOTIC SYNDROME; QUALITY OF LIFE; RECURRENCE; RISK ASSESSMENT; STOCKINGS, COMPRESSION; THROMBECTOMY; THROMBOLYTIC THERAPY; TIME FACTORS; TREATMENT OUTCOME; VASCULAR PATENCY; VENOUS THROMBOSIS; VENOUS VALVES;

EID: 77950896205     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/ATVBAHA.109.200766     Document Type: Review

References (40)

1. Cohen AT, Agnelli G, Anderson FA, Arcelus JI, Bergqvist D, Brecht JG, Greer IA, Heit JA, Hutchinson JL, Kakkar AK, Mottier D, Oger E, Samama MM, Spannagl M. Venous thromboembolism (VTE) in Europe: the number of VTE events and associated morbidity and mortality. Thromb Haemost. 2007;98:756-764.
2. Prandoni P, Lensing AW, Prins MH, Frulla M, Marchiori A, Bernardi E, Tormene D, Mosena L, Pagnan A, Girolami A. Below-knee elastic compression stockings to prevent the post-thrombotic syndrome: a randomized, controlled trial. Ann Intern Med. 2004;141:249-256.
3. Kahn SR, Shbaklo H, Lamping DL, Holcroft CA, Shrier I, Miron MJ, Roussin A, Desmarais S, Joyal F, Kassis J, Solymoss S, Desjardins L, Johri M, Ginsberg JS. Determinants of health-related quality of life during the 2 years following deep vein thrombosis. J Thromb Haemost. 2008;6:1105-1112.
4. Kahn SR, Partsch H, Vedantham S, Prandoni P, Kearon C, on behalf of the Subcommitee on the Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Definition of post-thrombotic syndrome of the leg for use in clinical investigations: a recommendation for standardization. J Thromb Haemost. 2009;7:879-1838
5. Weaver F, Meacham P, Adkins R, Dean R. Phlegmasia cerulea dolens: therapeutic considerations. South Med J. 1998;81:306-312.
6. Kahn S, Ginsberg J. The post-thrombotic syndrome: current knowledge, controversies, and directions for future research. Blood Rev. 2002;16: 155-165.
7. Buller H, Agnelli G, Hull R, Hyers TM, Prins MH, Raskob GE. Anti-thrombotic therapy for venous thromboembloic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126:401S-428S.
8. Meissner AJ, Misiak A, Ziemski JM, Scharf R, Rudowski W, Huszcza S Kucharski W, Wisławski S. Hazards of thrombolytic therapy in deep vein thrombosis. Br J Surg. 1987;74:991-993.
9. Comerota AJ, Aldridge SC. Thrombolytic therapy for deep venous thrombosis: a clinical review. Can J Surg. 1993;36:359-364.
10. Schweiter J, Kirch W, Koch R, Elix H, Hellner G, Forkmann L, Graf A. Short and long-term results after thrombolytic treatment of deep venous thrombosis. J Am Coll Cardiol. 2000;36:1343.
11. Watson L, Armon M. Thrombolysis for acute deep venous thrombosis. Cochrane Database Syst Rev. 2007;18:Art No. CD002783.
12. Protack C, Bakken A, Patel N, Saad W, Waldman D, Davies M. Long-term outcomes of catheter directed thrombolysis for lower extremity deep venous thrombosis without prophylactic inferior vena cava filter placement. J Vasc Surg. 2007;45:992-997.
13. Enden T, Klow NE, Sandvik L, Slagsvold CE, Ghanima W, Hafsahl G Holme PA, Holmen LO, Njaastad AM, Sandbaek G, Sandset PM. CaVenT study group. Catheter-directed thrombolysis vs. anticoagulant therapy alone in deep vein thrombosis: results of an open randomized, controlled trial reporting on short-term patency. J Thromb Haemost. 2009;7:1268-1275.
14. Baekgaard N, Broholm R, Just S, Jorgensen M, Jensen L. Long-term results using catheter-directed thrombolysis in 103 lower limbs with acute iliofemoral venous thrombosis. Eur J Vasc Endovasc Surg. 2010;39: 112-117.
15. Kearon C, Kahn S, Agnielli G, Goldhaber S, Raskob G, Comerota A. Antithrombotic therapy for venous thromboembolic disease: Am College of Chest Physicians evidence based clinical practice guidelines (8th edition). Chest. 2008;133:454S-545S.
16. Comerota AJ. The ATTRACT trial: rationale for early intervention for iliofemoral DVT. Perspect Vasc Surg Endovasc Ther. 2010 Jan 3 [E-pub ahead of print].
17. Enden T, Sandvik L, Klow N, Hafsahl G, Holme PA, Holman LO Ghanima W, Njaastad AM, Sandbaek G, Slagsvold CE, Sandset PM. Catheter-directed venous thrombolysis in acute iliofemoral vein thrombosis: the CaVenT study: rationale and design of a multicentre, randomized controlled, clinical trial (NCT00251771). Am Heart J. 2007;154: 808-814.
18. Segal J, Streiff M, Hofmann L, Thornton K, Bass E. Management of venous thromboembolism: a systematic review for a practice guideline. Ann Intern Med. 2007;146:211-222.
19. Meissner M. Thrombolytic therapy for acute deep vein thrombosis and the venous registry. Rev Cardiovasc Med. 2002;3:S53-S60. (Pubitemid 36221611)
20. Mewissen M. Catheter-directed thrombolysis for lower extremity deep vein thrombosis. Tech Vasc Interv Radiol. 2001;4:111-114.
21. McLafferty R. Endovascular management of deep venous thrombosis. Perspect Vasc Surg Endovasc Ther. 2008;20:87-91.
22. Strandness D Jr, Langlois Y, Cramer M, Randlett A. Long-term sequelae of acute venous thrombosis. JAMA. 1983;250:1289-1292.
23. Comerota A, Schmieder F. Intraoperative lytic therapy: agents and methods of administration. Semin Vasc Surg. 2001;14:132-142.
24. Mewissen M, Seabrook G, Meissner MH, Cynamon J, Labropoulos N, Haughton SH. Catheter-directed thrombolysis for lower extremity deep venous thrombosis: report of a national multicenter registry. Radiology. 1999;211:39-49.
25. Bjarnason H, Kruse JR, Asinger DA, Nazarian GK, Dieta CA Jr, Caldwell MD Key NS, Hirsch AT, Hunter DW. Iliofemoral deep venous thrombosis: safety and efficacy outcome during 5 years of catheter-directed thrombolytic therapy. J Vasc Interv Radiol. 1997;8:405-418.
26. Kibbe M, Ujiki M, Goodwin A, Eskandari M, Yao J, Matsumura J. Iliac vein compression in an asymptomatic patient population. J Vasc Surg. 2004;39:937-943.
27. Heniford B, Senler S, Olsofka J, Carrillo E, Bergamini T. May-Thurner syndrome: management by endovascular surgical techniques. Ann Vasc Surg. 1998;12:482-486.
28. Kim J, Choi D, Guk Ko Y, Park S, Jang Y, Lee do Y. Percutaneous treatment of deep vein thrombosis in May-Thurner syndrome. Cardiovasc Intervent Radiol. 2006;29:571-575.
29. Kwak H, Han Y, Lee Y, Jin G, Chung G. Stents in common iliac vein obstruction with acute ipsilateral deep thrombosis: early and late results. J Vasc Interv Radiol. 2005;16:815-822.
30. Husmann M, Heller G, Kalka C, Savolainen H, Do D, Schmidli J. Stenting of common iliac vein obstructions combined with regional thrombolysis and thrombectomy in acute deep vein thrombosis. Eur J Vasc Endovasc Surg. 2007;34:87-91.
31. Burroughs K. New considerations in the diagnosis and therapy of deep vein thrombosis. South Med J. 1999;92:517-520.
32. Rao A, Konig G, Leers SA, Cho J, Rhee RY, Makaroun MS, Chaer RA. Pharmacomechanical thrombectomy for iliofemoral deep vein thrombosis: an alternative in patients with contraindications to thrombolysis. J Vasc Surg. 2009;50:1092-1098.
33. Gandini R, Maspes F, Sodani G, Masala S, Assegnati G, Simonetti G. Percutaneous ilio-caval thrombectomy with the Amplatz device: preliminary results. Eur Radiol. 1999;9:951-958.
34. Elsharawy M, Elzayat E. Early results of thrombolysis vs. anticoagulation in iliofemoral venous thrombosis: a randomised clinical trial. Eur J Vasc Endovasc Surg. 2002;24:209-214.
35. Jackson L, Wang X, Dudrick S, Gersten G. Catheter directed thrombolysis and/or thrombectomy with selective endovascular stenting as alternatives to systemic anticoagulation for treatment of acute deep vein thrombosis. Am J Surg. 2005;190:864-868.
36. Lin P, Zhou W, Dardik A, Mussa F, Kougias P, Hedayati H. Catheter-direct thrombolysis versus pharmacomechanical thrombectomy for treatment of symptomatic lower extremity deep venous thrombosis. Am J Surg. 2006;192:782-788.
37. Shi H, Huang Y, Shen T, Xu Q. Percutaneous mechanical thrombectomy combined with catheter-directed thrombolysis in the treatment of symptomatic lower extremity deep venous thrombosis. Eur J Radiol. 2009;71: 350-355.
38. O'Sullivan GJ, Semba CP, Bittner CA, Kee ST, Razavi MK, Sze DY, Dake MD. Endovascular management of iliac vein compression (May-Thurner) syndrome. J Vasc Interv Radiol. 2000;11:823-836.
39. Patel NH, Stookey KR, Ketcham DB, Cragg AH. Endovascular management of acute extensive iliofemoral deep venous thrombosis caused by May-Thurner syndrome. J Vasc Interv Radiol. 2000;11:1297-1302.
40. Heijmen RH, Bollen TL, Duyndam DA, Overtoom TT, Van Den Berg JC, Moll FL. Endovascular venous stenting in May-Thurner syndrome. J Cardiovasc Surg (Torino). 2001;42:83-87.